Study to Investigate Efficacy and Safety Equivalence of OsvaRen Tablets and OsvaRen Granules
Phase of Trial: Phase II/III
Latest Information Update: 12 Sep 2016
Price : $35 *
At a glance
- Drugs Calcium acetate/magnesium carbonate (Primary) ; Phosphate binding modulators
- Indications Kidney disorders
- Focus Therapeutic Use
- Acronyms OsvaRen NEW
- Sponsors Fresenius Medical Care
- 09 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Apr 2015 Planned End Date changed from 1 May 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
- 29 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.